Calcium Isn't Hardening Your Arteries or increasing your CT calcium score the Way You Think
Why the source of your calcium matters more than the number on your labs and the vitamin K "brake" almost no one talks about.
Written by Dr Saneka Chakravarty, MD, FACC. Dr Chakravarty is a board-certified cardiovascular disease specialist focused on personalized preventive cardiovascular care.
Most people picture heart disease and high calcium score like scale building up in a pipe: calcium in your blood settles onto your artery walls, and the pipes slowly harden. It's intuitive, but not the real mechanism.
It's biology, not plumbing
Your body doesn't let calcium passively precipitate onto artery walls. Blood vessel calcification is an actively regulated process, closer to how bone forms than to mineral scaling in a pipe. Cells in the artery wall can switch into bone-building mode, driven by inflammation, phosphate, and a shifting balance of signals. Crucially, your arteries also come with built-in brakes: proteins whose job is to stop mineral from depositing. When they work, calcium stays in solution. When they fail, it gets laid down where it shouldn't.
So does blood calcium matter? Yes, but lot less than you'd think
Genetic studies (a method that filters out much of the usual statistical noise in regular clinical studies) show that modestly higher lifelong blood calcium does raise the risk of heart attack and coronary disease. So it's real, but a minor one.
The effect of calcium on heart disease is roughly on par with effect of triglycerides on the heart and clearly weaker than LDL cholesterol, blood pressure, and body weight.
There's no "calcium target" for heart prevention, and lowering a normal-range calcium hasn't been shown to prevent anything. If your calcium is genuinely high, the right first move is to figure our why- ruling out causes like an overactive parathyroid gland or kidney disease, not treating it as a heart lever.
The twist that is actionable: food vs. pill
This is the part almost no one hears and it flips the usual advice.
Calcium from food is not the problem. Higher dietary calcium isn't linked to more artery calcification, and may even trend the other way. The calcium in yogurt, leafy greens, and sardines is absorbed gradually and comes packaged with other nutrients.
Supplements may behave differently. A single 1,000 mg dose briefly spikes your blood calcium by about the same increment the genetic studies tie to higher heart risk. The outcome data are mixed: some analyses found a modest bump in heart attack risk, others found none, so this is a debated signal. Notably, the 2023 AHA/ACC guideline rates calcium supplements as offering no cardiovascular benefit.
The practical reading isn't "calcium is dangerous." It's: get your calcium from food, and be thoughtful about high-dose supplements, especially calcium taken alone, doses at or above 1,000 mg/day, particularly if you have diabetes or kidney disease. If you take calcium for your bones, that's a dose-and-form conversation with your physician, not a reason to stop on your own.
The brake: vitamin K and matrix Gla protein
Now the other half of the story. One of the most powerful natural brakes on calcification is a molecule called matrix Gla protein (MGP), a guard that keeps calcium from settling into the artery wall. But MGP only works once it's "switched on," and that switch is vitamin K–dependent. Too little vitamin K, and the brake stays off. Blood levels of the inactive form of MGP consistently track with faster calcium buildup.
The clearest proof comes from an unexpected place: the blood thinner warfarin, which works by blocking vitamin K, and in doing so switches off MGP. Longer warfarin use is associated with more coronary calcification, while the newer blood thinners called direct oral anticoagulants (DOACs), which don't touch vitamin K, aren't. This is not a reason to stop a prescribed blood thinner, warfarin is irreplaceable for some patients. It's a reason to ask your physician whether a different blood thinner fits your situation, if you have significant calcification.
Can vitamin K help your calcium score? Cautiously, maybe
Two solid recent trials of vitamin K2 (the MK-7 form) showed slowed calcium progression over two years, without making plaque more dangerous. Encouraging, with two caveats:
Slowing a calcium score isn't the same as preventing heart attacks. That proof doesn't yet exist.
The benefit isn't universal -results in advanced kidney disease and dialysis are inconsistent.
So vitamin K status is a modifiable piece of the puzzle, not a cure, and no substitute for the fundamentals.
What this means for you
Don't fixate on a normal-range calcium number. It adds little once your usual risk factors are known.
Get calcium from food, not by default from a bottle. Diet isn't linked to more calcification; high-dose supplements may be.
If you take a calcium supplement, revisit it with your physician — especially calcium alone, ≥1,000 mg/day, or with diabetes or kidney disease.
Put your energy where the leverage is: LDL (including ApoB and Lp(a)), blood pressure, blood sugar, weight, and inflammation.
On long-term warfarin with calcification? Ask about a DOAC. Bring your imaging.
Don't self-prescribe. Calcium and vitamin K interact with other treatments; the right answer is individual.
Hardened arteries aren't simply a calcium problem, they're a regulation problem.
Frequently asked questions
My calcium came back slightly high- should I worry about my heart? Within the normal range, calcium adds very little to your heart risk beyond what your other labs show, so a mild elevation isn't a reason to panic. If it's genuinely elevated, the first step is figuring out why (for example, checking your parathyroid function) not treating the number as a cardiovascular target. Some blood pressure medications, like thiazide diuretics, can nudge calcium up modestly too. Review it with your doctor.
Should I stop taking my calcium supplement? Not on your own, especially if you take it for bone health. The better move is to revisit the dose and form with your physician, lean on food sources where you can, and be extra thoughtful about high-dose (≥1,000 mg/day) calcium taken alone particularly if you have diabetes or kidney disease.
Does a high coronary calcium score mean my arteries are full of the calcium I eat? No. Calcification is a regulated, cell-driven process, not dietary calcium settling out of your blood. In fact, dense calcium can sometimes reflect a stabilized plaque. Your score is a useful risk marker, best used to decide how aggressively to manage LDL and blood pressure, not as a number to fear on its own.
Should I take vitamin K2 for my arteries? Trials show it can slow calcium progression, but it hasn't been proven to reduce heart attacks, so it's a "discuss with your doctor" item rather than a blanket recommendation. This is especially important if you take warfarin, because vitamin K directly interacts with it.
I'm on warfarin- is it calcifying my arteries? There's an association, but don't stop a prescribed blood thinner. If you have significant calcification, ask your physician whether a DOAC would be appropriate for you.
This article is for general education and is not medical advice. Decisions about supplements, anticoagulation, or any change to your treatment should be made with your own physician, who knows your full history.
References
Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction. Larsson SC, Burgess S, Michaëlsson K. JAMA. 2017;318(4):371-380. doi:10.1001/jama.2017.8981.
Mendelian randomization for cardiovascular diseases: principles and applications. Larsson SC, Butterworth AS, Burgess S. European Heart Journal. 2023;44(47):4913-4924. doi:10.1093/eurheartj/ehad736.
Impact of Serum Calcium and Phosphate on Coronary Atherosclerosis Detected by Cardiac Computed Tomography. Shin S, Kim KJ, Chang HJ, et al. European Heart Journal. 2012;33(22):2873-81. doi:10.1093/eurheartj/ehs152.
Coronary Artery Calcification: From Mechanism to Molecular Imaging. Nakahara T, Dweck MR, Narula N, et al. JACC. Cardiovascular Imaging. 2017;10(5):582-593. doi:10.1016/j.jcmg.2017.03.005.
Coronary Artery Calcification: Pathogenesis and Prognostic Implications. Madhavan MV, Tarigopula M, Mintz GS, et al. Journal of the American College of Cardiology. 2014;63(17):1703-14. doi:10.1016/j.jacc.2014.01.017.
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Circulation Research. 2011;109(6):697-711. doi:10.1161/CIRCRESAHA.110.234914.
Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification. Vossen LM, de Leeuw PW, Schurgers LJ, et al. JAMA Cardiology. 2026;11(8):719-726. doi:10.1001/jamacardio.2026.1279.
Primary Hyperparathyroidism Associated With Elevated Coronary Artery Calcium Scores and Increased Cardiovascular Risk. Bauzon JS, Romero-Velez G, Ramchand J, et al. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2026;32(4):558-564. doi:10.1016/j.eprac.2025.11.014.
Cardiovascular Involvement in Primary Hyperparathyroidism. Pepe J, Minisola S, Ettorre E, Desideri G, Cipriani C. The Journal of Clinical Endocrinology and Metabolism. 2025;:dgaf625. doi:10.1210/clinem/dgaf625.
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease. Hutcheson JD, Goettsch C. Circulation Research. 2023;132(8):993-1012. doi:10.1161/CIRCRESAHA.123.321760.
The Role of Matrix Gla Protein (MGP) in Vascular Calcification. Bjørklund G, Svanberg E, Dadar M, et al. Current Medicinal Chemistry. 2020;27(10):1647-1660. doi:10.2174/0929867325666180716104159.
Matrix Gla Protein and the Long-Term Incidence and Progression of Coronary Artery and Aortic Calcification in the Multi-Ethnic Study of Atherosclerosis. Berlot AA, Fu X, Shea MK, et al. Atherosclerosis. 2024;392:117505. doi:10.1016/j.atherosclerosis.2024.117505.
Association of Desphospho-Uncarboxylated Matrix Gla Protein With Incident Cardiovascular Disease and All-Cause Mortality: Results From the Prospective Bruneck Study. Willeit K, Santer P, Tschiderer L, et al. Atherosclerosis. 2022;353:20-27. doi:10.1016/j.atherosclerosis.2022.06.1017.
Circulating and Regional Matrix Gla Protein Indicating Plaque Calcification and Prognosis of Patients With ST-Segment Elevation Myocardial Infarction. Li J, Chen R, Zhao X, et al. Thrombosis and Haemostasis. 2026;126(5):537-549. doi:10.1055/a-2599-9386.
Extent of Arterial Calcification by Conventional Vitamin K Antagonist Treatment. Hasific S, Øvrehus KA, Gerke O, et al. PloS One. 2020;15(10):e0241450. doi:10.1371/journal.pone.0241450.
Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound. Andrews J, Psaltis PJ, Bayturan O, et al. JACC. Cardiovascular Imaging. 2018;11(9):1315-1323. doi:10.1016/j.jcmg.2017.04.010.
Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review. Dawson LP, Lum M, Nerleker N, Nicholls SJ, Layland J. Journal of the American College of Cardiology. 2022;79(1):66-82. doi:10.1016/j.jacc.2021.10.035.
Direct Oral Anticoagulants Versus Warfarin on Coronary Plaque in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Barbosa LM, Rodrigues Oliveira VM, Nunes MDCP, Moreira HG. Journal of Cardiovascular Pharmacology. 2025;:00005344-990000000-00518. doi:10.1097/FJC.0000000000001787.
Rivaroxaban Versus Vitamin K Antagonist Treatment on the Progression of Coronary Calcification: The IRIVASC-trial. Stöhr R, Reinartz S, Dirrichs T, et al. Scientific Reports. 2024;14(1):17605. doi:10.1038/s41598-024-67657-8.
Vitamin K2 and D3 Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial. Hasific S, Øvrehus KA, Mejldal A, et al. Circulation. 2026;. doi:10.1161/CIRCULATIONAHA.126.082363.
Vitamin K Status, Supplementation and Vascular Disease: A Systematic Review and Meta-Analysis. Lees JS, Chapman FA, Witham MD, Jardine AG, Mark PB. Heart (British Cardiac Society). 2019;105(12):938-945. doi:10.1136/heartjnl-2018-313955.
Vitamin K1 and Progression of Cardiovascular Calcifications in Hemodialysis Patients: The VitaVasK Randomized Controlled Trial. Saritas T, Reinartz S, Krüger T, et al. Clinical Kidney Journal. 2022;15(12):2300-2311. doi:10.1093/ckj/sfac184.
Inhibit Progression of Coronary Artery Calcification With Vitamin K in Hemodialysis Patients (The iPACK-HD Study): A Randomized, Placebo-Controlled Multi-Center, Pilot Trial. Holden RM, Booth SL, Zimmerman D, et al. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2023;38(3):746-756. doi:10.1093/ndt/gfac191.
Vitamin K Supplementation and Arterial Calcification in Dialysis: Results of the Double-Blind, Randomized, Placebo-Controlled RenaKvit Trial. Levy-Schousboe K, Frimodt-Møller M, Hansen D, et al. Clinical Kidney Journal. 2021;14(9):2114-2123. doi:10.1093/ckj/sfab017.
Randomized Controlled Clinical Trial of the Effect of Treatment With Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-Hdk). Haroon S, Davenport A, Ling LH, et al. Kidney International Reports. 2023;8(9):1741-1751. doi:10.1016/j.ekir.2023.06.011.
Vitamin K Deficiency: An Emerging Player in the Pathogenesis of Vascular Calcification and an Iatrogenic Consequence of Therapies in Advanced Renal Disease. Levy DS, Grewal R, Le TH. American Journal of Physiology. Renal Physiology. 2020;319(4):F618-F623. doi:10.1152/ajprenal.00278.2020.
Comments